United States Biotechnology & Medical Research

Agios Pharmaceuticals Inc (AGIO)

Track

Track

Agios Pharmaceuticals Inc. experienced significant insider selling activity recently, totaling over 2.1 million dollars. Chief Medical Officer Sarah Gheuens executed multiple planned divestments following the company's latest earnings report, which showed a 9.1% EPS beat. These transactions reflect ongoing liquidity events by key executives amidst a 20.6% stock price increase over the past quarter.
Ticker: AGIO Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Agios Pharmaceuticals Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Gheuens Sarah Chief Medical Officer Officer
Transaction date
Planned sale
Price
429.77
Quantity 92,910 +21.3%
Value US$4,656,252
SARAH GHEUENS Officer Officer
Transaction date
Proposed sale
Price
244.45
Quantity 40,005
Value US$359,720
Gheuens Sarah Chief Medical Officer Officer
Transaction date
Planned sale
Price
486.62
Quantity 5,112 +44.7%
Value US$3,076,625
Gheuens Sarah Officer Officer
Transaction date
Proposed sale
Price
37.56
Quantity 4,007
Value US$150,503
Gheuens Sarah Chief Medical Officer Officer
Transaction date
Planned sale
Price
34.71
Quantity 2,940 -3.5%
Value US$102,047
Jones Cecilia Chief Financial Officer Officer
Transaction date
Planned sale
Price
34.71
Quantity 3,141 -5.4%
Value US$109,024
2.9
Burns James William Chief Legal Officer Officer
Transaction date
Planned sale
Price
34.71
Quantity 3,280 -6.2%
Value US$113,849
Viswanadhan Krishnan Chief Corp Dev & Strategy Officer
Transaction date
Planned sale
Price
34.71
Quantity 2,959 -22.3%
Value US$102,707
2.3
Goff Brian Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
34.71
Quantity 6,596 -3.5%
Value US$228,947
2.3
Goff Brian Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
34.71
Quantity 12,472 -6.6%
Value US$432,903
Milanova Tsveta Chief Commercial Officer Officer
Transaction date
Planned sale
Price
34.71
Quantity 3,262 -6.5%
Value US$113,224
2.3
Goff Brian Officer; Director Executive Director
Transaction date
Proposed sale
Price
34.19
Quantity 19,068
Value US$651,935
Gheuens Sarah Officer Officer
Transaction date
Proposed sale
Price
34.19
Quantity 2,940
Value US$100,519
Jones Cecilia Officer Officer
Transaction date
Proposed sale
Price
34.19
Quantity 3,141
Value US$107,391
Milanova Tsveta Officer Officer
Transaction date
Proposed sale
Price
34.19
Quantity 3,262
Value US$111,528
2.9
Burns James William Officer Officer
Transaction date
Proposed sale
Price
34.19
Quantity 3,280
Value US$112,143
Viswanadhan Krishnan Officer Officer
Transaction date
Proposed sale
Price
34.19
Quantity 2,959
Value US$101,168
Viswanadhan Krishnan Chief Corp Dev & Strategy Officer
Transaction date
Planned sale
Price
27.80
Quantity 2,959 -36.5%
Value US$82,260
Viswanadhan Krishnan Officer Officer
Transaction date
Proposed sale
Price
29.00
Quantity 2,959
Value US$85,811
3.0
Washburn Theodore James Jr. Principal Accounting Officer Officer
Transaction date
Sale
Price
28.88
Quantity 5,272 -85.9%
Value US$152,255
2.3
Goff Brian Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
28.96
Quantity 5,918 -3.5%
Value US$171,385
2.3
Goff Brian Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
28.96
Quantity 8,267 -5.0%
Value US$239,412
2.3
Goff Brian Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
28.96
Quantity 3,870 -2.6%
Value US$112,075
Gheuens Sarah Chief Medical Officer Officer
Transaction date
Planned sale
Price
28.96
Quantity 1,187 -1.6%
Value US$34,376
Gheuens Sarah Chief Medical Officer Officer
Transaction date
Planned sale
Price
28.96
Quantity 1,681 -2.3%
Value US$48,682
Gheuens Sarah Chief Medical Officer Officer
Transaction date
Planned sale
Price
28.96
Quantity 1,187 -1.7%
Value US$34,376
2.9
Burns James William Chief Legal Officer Officer
Transaction date
Planned sale
Price
28.96
Quantity 1,163 -2.6%
Value US$33,680
2.9
Burns James William Chief Legal Officer Officer
Transaction date
Planned sale
Price
28.96
Quantity 1,187 -2.8%
Value US$34,376
2.9
Burns James William Chief Legal Officer Officer
Transaction date
Planned sale
Price
28.96
Quantity 1,681 -4.2%
Value US$48,682
2.9
Burns James William Chief Legal Officer Officer
Transaction date
Planned sale
Price
28.96
Quantity 1,187 -3.3%
Value US$34,376
Milanova Tsveta Chief Commercial Officer Officer
Transaction date
Planned sale
Price
28.96
Quantity 1,187 -2.8%
Value US$34,376
Milanova Tsveta Chief Commercial Officer Officer
Transaction date
Planned sale
Price
28.96
Quantity 1,681 -4.2%
Value US$48,682
3.0
Washburn Theodore James Jr. Principal Accounting Officer Officer
Transaction date
Planned sale
Price
28.96
Quantity 798 -11.5%
Value US$23,110
3.0
Washburn Theodore James Jr. Principal Accounting Officer Officer
Transaction date
Planned sale
Price
28.96
Quantity 727 -14.6%
Value US$21,054
3.0
Washburn Theodore James Jr. Principal Accounting Officer Officer
Transaction date
Planned sale
Price
28.96
Quantity 698 -21.2%
Value US$20,214
Jones Cecilia Chief Financial Officer Officer
Transaction date
Planned sale
Price
28.96
Quantity 1,573 -3.1%
Value US$45,554
Jones Cecilia Chief Financial Officer Officer
Transaction date
Planned sale
Price
28.96
Quantity 1,187 -2.5%
Value US$34,376
Jones Cecilia Chief Financial Officer Officer
Transaction date
Planned sale
Price
28.96
Quantity 1,681 -3.8%
Value US$48,682
Jones Cecilia Chief Financial Officer Officer
Transaction date
Planned sale
Price
28.96
Quantity 594 -1.5%
Value US$17,202
2.9
Burns James William Officer Officer
Transaction date
Proposed sale
Price
30.23
Quantity 5,218
Value US$157,740
2.3
Goff Brian Officer; Director Executive Director
Transaction date
Proposed sale
Price
30.23
Quantity 18,055
Value US$545,803
Milanova Tsveta Officer Officer
Transaction date
Proposed sale
Price
30.23
Quantity 2,868
Value US$86,700
Gheuens Sarah Officer Officer
Transaction date
Proposed sale
Price
30.23
Quantity 4,055
Value US$122,583
Jones Cecilia Officer Officer
Transaction date
Proposed sale
Price
30.23
Quantity 5,035
Value US$152,208
Milanova Tsveta Chief Commercial Officer Officer
Transaction date
Planned sale
Price
27.02
Quantity 2,872 -7.6%
Value US$77,601
Milanova Tsveta Officer Officer
Transaction date
Proposed sale
Price
27.22
Quantity 2,872
Value US$78,176
2.3
Goff Brian Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
27.09
Quantity 6,230 -4.2%
Value US$168,771
2.3
Goff Brian Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
27.09
Quantity 12,473 -8.4%
Value US$337,894
2.9
Burns James William Chief Legal Officer Officer
Transaction date
Planned sale
Price
27.09
Quantity 2,932 -8.5%
Value US$79,428
Milanova Tsveta Chief Commercial Officer Officer
Transaction date
Planned sale
Price
27.09
Quantity 2,932 -9.1%
Value US$79,428
Jones Cecilia Chief Financial Officer Officer
Transaction date
Planned sale
Price
27.09
Quantity 2,932 -7.3%
Value US$79,428
Gheuens Sarah Chief Medical Officer Officer
Transaction date
Planned sale
Price
27.09
Quantity 2,932 -4.3%
Value US$79,428
2.3
Goff Brian Officer; Director Executive Director
Transaction date
Proposed sale
Price
27.16
Quantity 18,703
Value US$507,973
Gheuens Sarah Officer Officer
Transaction date
Proposed sale
Price
27.16
Quantity 2,932
Value US$79,633
Jones Cecilia Officer Officer
Transaction date
Proposed sale
Price
27.16
Quantity 2,932
Value US$79,633
Milanova Tsveta Officer Officer
Transaction date
Proposed sale
Price
27.16
Quantity 2,932
Value US$79,633
2.9
Burns James William Officer Officer
Transaction date
Proposed sale
Price
27.16
Quantity 2,932
Value US$79,633
Scadden David Non-Executive Director
Transaction date
Planned sale
Price
43.84
Quantity 200 -1.1%
Value US$8,768
Gheuens Sarah Chief Medical Officer Officer
Transaction date
Planned sale
Price
43.78
Quantity 2,454 -3.8%
Value US$107,436
SARAH GHEUENS Officer Officer
Transaction date
Proposed sale
Price
43.78
Quantity 2,454
Value US$107,441
Gheuens Sarah Chief Medical Officer Officer
Transaction date
Planned sale
Price
43.81
Quantity 200 -0.3%
Value US$8,762
SARAH GHEUENS Officer Officer
Transaction date
Proposed sale
Price
43.81
Quantity 200
Value US$8,762
Gheuens Sarah Chief Medical Officer Officer
Transaction date
Planned sale
Price
43.92
Quantity 3,302 -5.1%
Value US$145,024
SARAH GHEUENS Officer Officer
Transaction date
Proposed sale
Price
43.92
Quantity 3,302
Value US$145,028
Scadden David Non-Executive Director
Transaction date
Planned sale
Price
41.00
Quantity 200 -1.1%
Value US$8,200
DAVID SCADDEN Director Non-Executive Director
Transaction date
Proposed sale
Price
41.00
Quantity 200
Value US$8,200
Scadden David Non-Executive Director
Transaction date
Planned sale
Price
40.00
Quantity 200 -1.1%
Value US$8,000
Jones Cecilia Chief Financial Officer Officer
Transaction date
Planned sale
Price
36.77
Quantity 3,651 -9.7%
Value US$134,247
Jones Cecilia Officer Officer
Transaction date
Proposed sale
Price
36.77
Quantity 3,651
Value US$134,247
3.0
Washburn Theodore James Jr. Principal Accounting Officer Officer
Transaction date
Sale
Price
36.87
Quantity 8,546 -90.8%
Value US$315,091
Scadden David Non-Executive Director
Transaction date
Planned sale
Price
40.00
Quantity 200 -1.1%
Value US$8,000
DAVID T. SCADDEN Director Non-Executive Director
Transaction date
Proposed sale
Price
40.00
Quantity 200
Value US$8,000
2.3
Goff Brian Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
36.67
Quantity 11,085 -8.2%
Value US$406,487
2.3
Goff Brian Officer; Director Executive Director
Transaction date
Proposed sale
Price
37.06
Quantity 11,085
Value US$410,810
Scadden David Non-Executive Director
Transaction date
Planned sale
Price
40.00
Quantity 1,400 -7.4%
Value US$56,000
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-08-06 2026-08-04 PlS Planned sale
Gheuens Sarah

Chief Medical Officer

Officer
92,910 +21.3%
429.77
US$4,656,252 		92,910 +21.3% 429.77 US$4,656,252
2026-08-04 2026-08-04 PrS Proposed sale
SARAH GHEUENS

Officer

Officer
40,005
244.45
US$359,720 		40,005 244.45 US$359,720
2026-07-02 2026-07-01 PlS Planned sale
Gheuens Sarah

Chief Medical Officer

Officer
5,112 +44.7%
486.62
US$3,076,625 		5,112 +44.7% 486.62 US$3,076,625
2026-07-01 2026-07-01 PrS Proposed sale
Gheuens Sarah

Officer

Officer
4,007
37.56
US$150,503 		4,007 37.56 US$150,503
2026-04-06 2026-04-02 PlS Planned sale
Gheuens Sarah

Chief Medical Officer

Officer
2,940 -3.5%
34.71
US$102,047 		2,940 -3.5% 34.71 US$102,047
2026-04-06 2026-04-02 PlS Planned sale
Jones Cecilia

Chief Financial Officer

Officer
3,141 -5.4%
34.71
US$109,024 		3,141 -5.4% 34.71 US$109,024
2026-04-06 2026-04-02 PlS Planned sale
2.9
Burns James William

Chief Legal Officer

Officer
3,280 -6.2%
34.71
US$113,849 		3,280 -6.2% 34.71 US$113,849
2026-04-06 2026-04-02 PlS Planned sale
Viswanadhan Krishnan

Chief Corp Dev & Strategy

Officer
2,959 -22.3%
34.71
US$102,707 		2,959 -22.3% 34.71 US$102,707
2026-04-06 2026-04-02 PlS Planned sale
2.3
Goff Brian

Chief Executive Officer

Executive Director
6,596 -3.5%
34.71
US$228,947 		6,596 -3.5% 34.71 US$228,947
2026-04-06 2026-04-02 PlS Planned sale
2.3
Goff Brian

Chief Executive Officer

Executive Director
12,472 -6.6%
34.71
US$432,903 		12,472 -6.6% 34.71 US$432,903
2026-04-06 2026-04-02 PlS Planned sale
Milanova Tsveta

Chief Commercial Officer

Officer
3,262 -6.5%
34.71
US$113,224 		3,262 -6.5% 34.71 US$113,224
2026-04-02 2026-04-02 PrS Proposed sale
2.3
Goff Brian

Officer; Director

Executive Director
19,068
34.19
US$651,935 		19,068 34.19 US$651,935
2026-04-02 2026-04-02 PrS Proposed sale
Gheuens Sarah

Officer

Officer
2,940
34.19
US$100,519 		2,940 34.19 US$100,519
2026-04-02 2026-04-02 PrS Proposed sale
Jones Cecilia

Officer

Officer
3,141
34.19
US$107,391 		3,141 34.19 US$107,391
2026-04-02 2026-04-02 PrS Proposed sale
Milanova Tsveta

Officer

Officer
3,262
34.19
US$111,528 		3,262 34.19 US$111,528
2026-04-02 2026-04-02 PrS Proposed sale
2.9
Burns James William

Officer

Officer
3,280
34.19
US$112,143 		3,280 34.19 US$112,143
2026-04-02 2026-04-02 PrS Proposed sale
Viswanadhan Krishnan

Officer

Officer
2,959
34.19
US$101,168 		2,959 34.19 US$101,168
2026-03-09 2026-03-05 PlS Planned sale
Viswanadhan Krishnan

Chief Corp Dev & Strategy

Officer
2,959 -36.5%
27.80
US$82,260 		2,959 -36.5% 27.80 US$82,260
2026-03-05 2026-03-05 PrS Proposed sale
Viswanadhan Krishnan

Officer

Officer
2,959
29.00
US$85,811 		2,959 29.00 US$85,811
2026-03-05 2026-03-03 S Sale
3.0
Washburn Theodore James Jr.

Principal Accounting Officer

Officer
5,272 -85.9%
28.88
US$152,255 		5,272 -85.9% 28.88 US$152,255
2026-03-03 2026-03-02 PlS Planned sale
2.3
Goff Brian

Chief Executive Officer

Executive Director
5,918 -3.5%
28.96
US$171,385 		5,918 -3.5% 28.96 US$171,385
2026-03-03 2026-03-02 PlS Planned sale
2.3
Goff Brian

Chief Executive Officer

Executive Director
8,267 -5.0%
28.96
US$239,412 		8,267 -5.0% 28.96 US$239,412
2026-03-03 2026-03-02 PlS Planned sale
2.3
Goff Brian

Chief Executive Officer

Executive Director
3,870 -2.6%
28.96
US$112,075 		3,870 -2.6% 28.96 US$112,075
2026-03-03 2026-03-02 PlS Planned sale
Gheuens Sarah

Chief Medical Officer

Officer
1,187 -1.6%
28.96
US$34,376 		1,187 -1.6% 28.96 US$34,376
2026-03-03 2026-03-02 PlS Planned sale
Gheuens Sarah

Chief Medical Officer

Officer
1,681 -2.3%
28.96
US$48,682 		1,681 -2.3% 28.96 US$48,682
2026-03-03 2026-03-02 PlS Planned sale
Gheuens Sarah

Chief Medical Officer

Officer
1,187 -1.7%
28.96
US$34,376 		1,187 -1.7% 28.96 US$34,376
2026-03-03 2026-03-02 PlS Planned sale
2.9
Burns James William

Chief Legal Officer

Officer
1,163 -2.6%
28.96
US$33,680 		1,163 -2.6% 28.96 US$33,680
2026-03-03 2026-03-02 PlS Planned sale
2.9
Burns James William

Chief Legal Officer

Officer
1,187 -2.8%
28.96
US$34,376 		1,187 -2.8% 28.96 US$34,376
2026-03-03 2026-03-02 PlS Planned sale
2.9
Burns James William

Chief Legal Officer

Officer
1,681 -4.2%
28.96
US$48,682 		1,681 -4.2% 28.96 US$48,682
2026-03-03 2026-03-02 PlS Planned sale
2.9
Burns James William

Chief Legal Officer

Officer
1,187 -3.3%
28.96
US$34,376 		1,187 -3.3% 28.96 US$34,376
2026-03-03 2026-03-02 PlS Planned sale
Milanova Tsveta

Chief Commercial Officer

Officer
1,187 -2.8%
28.96
US$34,376 		1,187 -2.8% 28.96 US$34,376
2026-03-03 2026-03-02 PlS Planned sale
Milanova Tsveta

Chief Commercial Officer

Officer
1,681 -4.2%
28.96
US$48,682 		1,681 -4.2% 28.96 US$48,682
2026-03-03 2026-03-02 PlS Planned sale
3.0
Washburn Theodore James Jr.

Principal Accounting Officer

Officer
798 -11.5%
28.96
US$23,110 		798 -11.5% 28.96 US$23,110
2026-03-03 2026-03-02 PlS Planned sale
3.0
Washburn Theodore James Jr.

Principal Accounting Officer

Officer
727 -14.6%
28.96
US$21,054 		727 -14.6% 28.96 US$21,054
2026-03-03 2026-03-02 PlS Planned sale
3.0
Washburn Theodore James Jr.

Principal Accounting Officer

Officer
698 -21.2%
28.96
US$20,214 		698 -21.2% 28.96 US$20,214
2026-03-03 2026-03-02 PlS Planned sale
Jones Cecilia

Chief Financial Officer

Officer
1,573 -3.1%
28.96
US$45,554 		1,573 -3.1% 28.96 US$45,554
2026-03-03 2026-03-02 PlS Planned sale
Jones Cecilia

Chief Financial Officer

Officer
1,187 -2.5%
28.96
US$34,376 		1,187 -2.5% 28.96 US$34,376
2026-03-03 2026-03-02 PlS Planned sale
Jones Cecilia

Chief Financial Officer

Officer
1,681 -3.8%
28.96
US$48,682 		1,681 -3.8% 28.96 US$48,682
2026-03-03 2026-03-02 PlS Planned sale
Jones Cecilia

Chief Financial Officer

Officer
594 -1.5%
28.96
US$17,202 		594 -1.5% 28.96 US$17,202
2026-03-02 2026-03-02 PrS Proposed sale
2.9
Burns James William

Officer

Officer
5,218
30.23
US$157,740 		5,218 30.23 US$157,740
2026-03-02 2026-03-02 PrS Proposed sale
2.3
Goff Brian

Officer; Director

Executive Director
18,055
30.23
US$545,803 		18,055 30.23 US$545,803
2026-03-02 2026-03-02 PrS Proposed sale
Milanova Tsveta

Officer

Officer
2,868
30.23
US$86,700 		2,868 30.23 US$86,700
2026-03-02 2026-03-02 PrS Proposed sale
Gheuens Sarah

Officer

Officer
4,055
30.23
US$122,583 		4,055 30.23 US$122,583
2026-03-02 2026-03-02 PrS Proposed sale
Jones Cecilia

Officer

Officer
5,035
30.23
US$152,208 		5,035 30.23 US$152,208
2026-01-07 2026-01-05 PlS Planned sale
Milanova Tsveta

Chief Commercial Officer

Officer
2,872 -7.6%
27.02
US$77,601 		2,872 -7.6% 27.02 US$77,601
2026-01-05 2026-01-05 PrS Proposed sale
Milanova Tsveta

Officer

Officer
2,872
27.22
US$78,176 		2,872 27.22 US$78,176
2026-01-02 2025-12-30 PlS Planned sale
2.3
Goff Brian

Chief Executive Officer

Executive Director
6,230 -4.2%
27.09
US$168,771 		6,230 -4.2% 27.09 US$168,771
2026-01-02 2025-12-30 PlS Planned sale
2.3
Goff Brian

Chief Executive Officer

Executive Director
12,473 -8.4%
27.09
US$337,894 		12,473 -8.4% 27.09 US$337,894
2026-01-02 2025-12-30 PlS Planned sale
2.9
Burns James William

Chief Legal Officer

Officer
2,932 -8.5%
27.09
US$79,428 		2,932 -8.5% 27.09 US$79,428
2026-01-02 2025-12-30 PlS Planned sale
Milanova Tsveta

Chief Commercial Officer

Officer
2,932 -9.1%
27.09
US$79,428 		2,932 -9.1% 27.09 US$79,428
2026-01-02 2025-12-30 PlS Planned sale
Jones Cecilia

Chief Financial Officer

Officer
2,932 -7.3%
27.09
US$79,428 		2,932 -7.3% 27.09 US$79,428
2026-01-02 2025-12-30 PlS Planned sale
Gheuens Sarah

Chief Medical Officer

Officer
2,932 -4.3%
27.09
US$79,428 		2,932 -4.3% 27.09 US$79,428
2025-12-30 2025-12-30 PrS Proposed sale
2.3
Goff Brian

Officer; Director

Executive Director
18,703
27.16
US$507,973 		18,703 27.16 US$507,973
2025-12-30 2025-12-30 PrS Proposed sale
Gheuens Sarah

Officer

Officer
2,932
27.16
US$79,633 		2,932 27.16 US$79,633
2025-12-30 2025-12-30 PrS Proposed sale
Jones Cecilia

Officer

Officer
2,932
27.16
US$79,633 		2,932 27.16 US$79,633
2025-12-30 2025-12-30 PrS Proposed sale
Milanova Tsveta

Officer

Officer
2,932
27.16
US$79,633 		2,932 27.16 US$79,633
2025-12-30 2025-12-30 PrS Proposed sale
2.9
Burns James William

Officer

Officer
2,932
27.16
US$79,633 		2,932 27.16 US$79,633
2025-11-14 2025-11-12 PlS Planned sale
Scadden David
Non-Executive Director
200 -1.1%
43.84
US$8,768 		200 -1.1% 43.84 US$8,768
2025-11-13 2025-11-11 PlS Planned sale
Gheuens Sarah

Chief Medical Officer

Officer
2,454 -3.8%
43.78
US$107,436 		2,454 -3.8% 43.78 US$107,436
2025-11-12 2025-11-11 PrS Proposed sale
SARAH GHEUENS

Officer

Officer
2,454
43.78
US$107,441 		2,454 43.78 US$107,441
2025-11-03 2025-10-30 PlS Planned sale
Gheuens Sarah

Chief Medical Officer

Officer
200 -0.3%
43.81
US$8,762 		200 -0.3% 43.81 US$8,762
2025-10-30 2025-10-30 PrS Proposed sale
SARAH GHEUENS

Officer

Officer
200
43.81
US$8,762 		200 43.81 US$8,762
2025-10-29 2025-10-27 PlS Planned sale
Gheuens Sarah

Chief Medical Officer

Officer
3,302 -5.1%
43.92
US$145,024 		3,302 -5.1% 43.92 US$145,024
2025-10-27 2025-10-27 PrS Proposed sale
SARAH GHEUENS

Officer

Officer
3,302
43.92
US$145,028 		3,302 43.92 US$145,028
2025-10-10 2025-10-08 PlS Planned sale
Scadden David
Non-Executive Director
200 -1.1%
41.00
US$8,200 		200 -1.1% 41.00 US$8,200
2025-10-08 2025-10-08 PrS Proposed sale
DAVID SCADDEN

Director

Non-Executive Director
200
41.00
US$8,200 		200 41.00 US$8,200
2025-10-02 2025-09-30 PlS Planned sale
Scadden David
Non-Executive Director
200 -1.1%
40.00
US$8,000 		200 -1.1% 40.00 US$8,000
2025-09-30 2025-09-26 PlS Planned sale
Jones Cecilia

Chief Financial Officer

Officer
3,651 -9.7%
36.77
US$134,247 		3,651 -9.7% 36.77 US$134,247
2025-09-26 2025-09-26 PrS Proposed sale
Jones Cecilia

Officer

Officer
3,651
36.77
US$134,247 		3,651 36.77 US$134,247
2025-09-09 2025-09-05 S Sale
3.0
Washburn Theodore James Jr.

Principal Accounting Officer

Officer
8,546 -90.8%
36.87
US$315,091 		8,546 -90.8% 36.87 US$315,091
2025-08-29 2025-08-27 PlS Planned sale
Scadden David
Non-Executive Director
200 -1.1%
40.00
US$8,000 		200 -1.1% 40.00 US$8,000
2025-08-27 2025-08-27 PrS Proposed sale
DAVID T. SCADDEN

Director

Non-Executive Director
200
40.00
US$8,000 		200 40.00 US$8,000
2025-08-12 2025-08-08 PlS Planned sale
2.3
Goff Brian

Chief Executive Officer

Executive Director
11,085 -8.2%
36.67
US$406,487 		11,085 -8.2% 36.67 US$406,487
2025-08-08 2025-08-08 PrS Proposed sale
2.3
Goff Brian

Officer; Director

Executive Director
11,085
37.06
US$410,810 		11,085 37.06 US$410,810
2025-07-15 2025-07-10 PlS Planned sale
Scadden David
Non-Executive Director
1,400 -7.4%
40.00
US$56,000 		1,400 -7.4% 40.00 US$56,000
Explore more

More insider trading research around Agios Pharmaceuticals Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America